Methylphenidate has dose-dependent negative effects on rat spermatogenesis: decreased round spermatids and testicular

Ali Cansu1, Ozgür Ekinci, Ozalp Ekinci

  • 1Department of Pediatric Neurology, Karadeniz Technical University Faculty of Medicine, Trabzon, Turkey.

Insights

Methylphenidate (MPH) may negatively impact rat testes, reducing testicular weight and sperm count. It also increases cell death and p53 activation, suggesting potential reproductive toxicity.

Area of Science:

  • Reproductive Toxicology
  • Pharmacology
  • Histopathology

Background:

  • Methylphenidate (MPH) is a widely prescribed stimulant medication.
  • Potential adverse effects on male reproductive health require thorough investigation.

Purpose of the Study:

  • To investigate the effects of methylphenidate on rat testicular function and spermatogenesis.
  • To assess histological and molecular changes in testes following MPH administration.

Main Methods:

  • Wistar rats were administered varying doses of methylphenidate (5 and 10 mg/kg/day) or tap water (control) for 90 days.
  • Evaluated body and testicular weights, performed histopathological analysis, and quantified cell populations.
  • Assessed p53 and TGF-β1 expression via immunohistochemistry and measured apoptosis using the TUNEL assay.

Main Results:

  • Methylphenidate administration led to reduced testicular weight and decreased round spermatids in specific stages.
  • Increased p53 expression and elevated apoptotic index were observed in the high-dose group.
  • Reduced TGF-β1 expression was noted in both MPH-treated groups.

Conclusions:

  • Methylphenidate may adversely affect spermatogenesis by reducing testicular weight, impairing sperm development, increasing apoptosis, and activating p53.
  • Findings suggest potential reproductive risks associated with methylphenidate use, warranting cautious interpretation.

Related Concept Videos

Spermatogenesis01:41

Spermatogenesis

Spermatogenesis is the process by which haploid sperm cells are produced in the male testes. It starts with stem cells located close to the outer rim of seminiferous tubules. These spermatogonial stem cells divide asymmetrically to give rise to additional stem cells (meaning that these structures “self-renew”), as well as sperm progenitors, called spermatocytes. Importantly, this method of asymmetric mitotic division maintains a population of spermatogonial stem cells in the male reproductive...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Phase II Reactions: Methylation Reactions01:17

Phase II Reactions: Methylation Reactions

Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...